Barrett's Esophagus (BE) Studies

CEDAS research studies that are currently enrolling participants with Barrett's Esophagus (BE)

A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett’s Esophagus with trūFreeze™ Spray Cryotherapy (DOSE Study).

CSA TruFreeze Website

CURRENTLY ENROLLING! Please contact us if interested:

Purpose: This post-marketing study is being conducted to determine the optimum starting dose of spray cryotherapy for the treatment of dysplastic Barrett’s Esophagus (BE).  Patients undergoing ablation with the FDA-approved truFreezeTM cryotherapy device will be assigned to receive one of four pre-determined starting doses of cryotherapy.  All doses used in the study fall within the currently recommended therapeutic range for the treatment of BE.   
Participants: Patients aged 18-85 presenting at the Gl Endoscopy Clinic at UNC-Chapel Hill for elective ablation of their BE with low- or high-grade dysplasia.
Procedures (methods): Patients will receive one spray cryotherapy treatment via endoscopy and complete a brief telephone interview following the procedure.  The initial treatment endoscopy is paid for by the study sponsor.  Follow-up endoscopies or BE treatments, if needed, are at the discretion of the patient’s primary doctor and are not covered by the study.
Principal Investigator: Dr. Nicholas Shaheen, MD, MPH
: CSA Medical, Inc.CSA medical.jpg

Clinical website for this study: TruFreeze Cryotherapy

Please contact us for more information:

Familial Barrett's Esophagus (FBE) Study

We are currently enrolling patients with Barrett's esophagus (BE) with a family history of BE or esophageal cancer.

Clinical website for this study: Familial BE

Please contact us for more information: